What is the comparison between Apixaban and Aspirin in AF patients?
Apixaban is the only NOAC that has been compared with aspirin in AF patients. The results of the study showed that Apixaban is associated with a reduced risk of stroke or systemic embolism, major bleeding, and all-cause mortality compared to aspirin.